AAAAI: Omalizumab as effective as multifood oral immunotherapy for individuals with food allergy
by Elana Gotkine edited by Gaby Clark, reviewed by Alexander Pol Editors’ notes The GIST Add as preferred source Individuals with one to three allergenic foods are able to introduce and continue eating allergenic foods at 12 months after multifood oral immunotherapy (mOIT) or omalizumab, according to a study presented at the annual meeting of the American […]
